Akeso, Inc.

24 APR 2020

Akeso, Inc. is a clinical-stage biopharmaceutical company committed to in-house discovery, development and commercialization of first-in-class and best-in-class therapies. Akeso is dedicated to addressing global unmet medical needs in oncology, immunology and other therapeutic areas with its R&D platform that integrates drug development and manufacturing capabilities. Akeso’s vision is to become a global leader in developing, manufacturing and commercializing innovative, next-generation and affordable therapeutic antibodies for patients worldwide.